TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 186 filers reported holding TANDEM DIABETES CARE INC in Q3 2018. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,114,204 | +25.0% | 14,046 | -0.9% | 0.03% | +16.0% |
| Q3 2021 | $1,691,973 | +329.2% | 14,173 | +250.2% | 0.02% | +316.7% |
| Q2 2021 | $394,178 | +10.2% | 4,047 | -0.1% | 0.01% | +20.0% |
| Q1 2021 | $357,589 | -11.5% | 4,052 | -4.0% | 0.01% | -16.7% |
| Q4 2020 | $404,057 | -15.6% | 4,223 | +0.1% | 0.01% | -25.0% |
| Q3 2020 | $478,857 | +13.4% | 4,219 | -1.2% | 0.01% | +14.3% |
| Q2 2020 | $422,289 | -61.3% | 4,269 | -74.8% | 0.01% | -69.6% |
| Q1 2020 | $1,091,376 | +3.4% | 16,960 | -4.2% | 0.02% | +27.8% |
| Q4 2019 | $1,055,097 | -0.4% | 17,700 | -1.5% | 0.02% | 0.0% |
| Q3 2019 | $1,059,694 | -2.0% | 17,967 | +7.2% | 0.02% | 0.0% |
| Q2 2019 | $1,081,548 | +3.5% | 16,763 | +1.9% | 0.02% | -5.3% |
| Q1 2019 | $1,044,893 | +62.9% | 16,455 | -2.6% | 0.02% | +46.2% |
| Q4 2018 | $641,275 | -9.0% | 16,889 | +2.7% | 0.01% | 0.0% |
| Q3 2018 | $704,589 | – | 16,447 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |